PLASMA PURCHASE AGREEMENTPlasma Purchase Agreement • August 11th, 2017 • Adma Biologics, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS PLASMA PURCHASE AGREEMENT (“Agreement”) between Biotest Pharmaceuticals Corporation, a Delaware corporation, having a place of business at 5800 Park of Commerce Boulevard, NW, Boca Raton, Florida 33487 (“BPC”) and ADMA BioManufacturing, LLC., a Delaware limited liability corporation, having a place of business at 465 Route 17 South, Ramsey New Jersey 07446 (“ADMA”) shall be effective as of June 6, 2017 (the “Effective Date”). BPC and ADMA are each sometimes referred to herein individually as a “Party” or collectively as the “Parties”.
FIRST AMENDMENT TO LICENSE AGREEMENTLicense Agreement • August 11th, 2017 • Adma Biologics, Inc. • Biological products, (no disgnostic substances)
This First Amendment to the License Agreement (“Amendment #1”) by and between Biotest Aktiengesellschaft, a corporation organized under the laws of Germany ("Biotest"), and ADMA Biologics, Inc., a Delaware corporation ("ADMA"), is effective as of June 6, 2017 (“Effective Date”). ADMA and Biotest are also referred to herein individually as a “Party” and collectively as the “Parties”.
TERMINATION AGREEMENT (MANUFACTURING, SUPPLY AND LICENSE AGREEMENT AND MASTER SERVICES AGREEMENT)Termination Agreement • August 11th, 2017 • Adma Biologics, Inc. • Biological products, (no disgnostic substances) • Delaware
This TERMINATION AGREEMENT (Manufacturing, Supply and License Agreement and Master Services Agreement), dated as of June 6, 2017 (this “Termination Agreement”), is made and entered into by and between ADMA Biologics, Inc., a Delaware corporation (“ADMA”), and Biotest Pharmaceuticals Corporation, a Delaware corporation (“BPC”). Each of ADMA and BPC are sometimes individually referred to herein as a “Party”, and collectively as the “Parties”. Capitalized terms used herein but not otherwise defined herein shall have the meanings ascribed to such terms in the Purchase Agreement (as defined below).
PURCHASE AGREEMENTPurchase Agreement • August 11th, 2017 • Adma Biologics, Inc. • Biological products, (no disgnostic substances) • Delaware
This Purchase Agreement (“Agreement”) is made effective as of the 6th day of June, 2017 (the “Execution Date”), by and among (i) Biotest Pharmaceuticals Corporation, a Delaware corporation (“Buyer”), (ii) ADMA Bio Centers Georgia, Inc., a Delaware corporation (“ADMA BioCenters”) and (iii) ADMA Biologics, Inc., a Delaware corporation (“ADMA Biologics”, and together with ADMA BioCenters, the “Seller”). The Buyer and the Seller sometimes are referred to collectively herein as the “Parties” and individually as a “Party.” Except as otherwise expressly provided herein, capitalized terms used in this Agreement shall have the meanings set forth in Annex A.
PLASMA SUPPLY AGREEMENT (HEPATITIS B PLASMA - BPC TO ADMA)Plasma Supply Agreement • August 11th, 2017 • Adma Biologics, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS PLASMA SUPPLY AGREEMENT (this “Agreement”) between Biotest Pharmaceuticals Corporation, a Delaware corporation, having a place of business at 5800 Park of Commerce Boulevard, NW, Boca Raton, Florida 33487 (“BPC”) and ADMA BioManufacturing, LLC, a Delaware limited liability company, having a place of business at 5800 Park of Commerce Boulevard NW, Boca Raton, Florida 33487 (“ADMA”), shall be effective as of June 6, 2017 (the “Effective Date”). BPC and ADMA are each sometimes referred to herein individually as a “Party” or collectively as the “Parties”.
FOURTH AMENDMENT TO PLASMA PURCHASE AGREEMENTPlasma Purchase Agreement • August 11th, 2017 • Adma Biologics, Inc. • Biological products, (no disgnostic substances)
This Fourth Amendment to the Plasma Purchase Agreement (this “Amendment #4”) by and between Biotest Pharmaceuticals Corporation, a Delaware corporation having a place of business at 5800 Park of Commerce Boulevard, NW, Boca Raton, Florida 33487(“BPC”) and ADMA Biologics, Inc., a Delaware corporation having a place of business at 465 Route 17 South, Ramsey, New Jersey 07446 (“ADMA”) is effective as of June 6, 2017 (the “ Effective Date”).
TRANSITION SERVICES AGREEMENT by and between ADMA BIOMANUFACTURING, LLC and BIOTEST PHARMACEUTICALS CORPORATION Dated as of June 6, 2017Transition Services Agreement • August 11th, 2017 • Adma Biologics, Inc. • Biological products, (no disgnostic substances) • Delaware
TRANSITION SERVICES AGREEMENT (this “Agreement”), dated as of June 6, 2017, by and between ADMA BioManufacturing, LLC, a Delaware limited liability company (“ADMA”), and Biotest Pharmaceuticals Corporation, a Delaware corporation (“BPC”). ADMA and BPC shall be separately referred to herein as a “Party” and together as the “Parties.”
